Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-30
1994-05-10
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31505
Patent
active
053107420
ABSTRACT:
This invention provides new uses for the drugs of the thioureylene class and thiabendazole. These new uses include methods of treatment for a variety of conditions and diseases, including psoriasis, other atopic dermatoses and inflammatory conditions having an autoimmune basis, as well as other autoimmune diseases, including rheumatic disease, and transplant rejection.
REFERENCES:
patent: 4457907 (1984-07-01), Porter
patent: 4608341 (1986-08-01), Ambesi-Impiombato
patent: 4609622 (1986-09-01), Kohn et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4711782 (1987-12-01), Okada et al.
patent: 4853227 (1989-08-01), Kurihara-Bergstrom et al.
patent: 4917893 (1990-04-01), Okada et al.
patent: 4954298 (1990-09-01), Yamamoto et al.
patent: 5010092 (1991-03-01), Elfarra
patent: 5061492 (1991-10-01), Okada
patent: 5087441 (1992-02-01), Elfarra
patent: 5100669 (1992-03-01), Hyon et al.
Physician's Desk Reference, pp. 1298-1299, 1510-1511, 1992.
"Effects of Methimazole on Human Lymphocyte Proliferation and Natural Killer Cell Activity," by Brahma S. Sharma and Alan N. Elias, Department of Medicine, University of California at Irvine, vol. 18(4): pp. 449-453, (1987).
"The Immunosuppressive Effect of Methimazole on Cell-Mediated Immunity Is Mediated By Its Capacity To Inhibit Peroxidase and To Scavenge Free Oxygen Radicals," by Csaba Balazs, et al., vol. 25: pp. 7-15, (1986).
"Anti-Thyroid Drugs and Lymphocyte Function, II, The In Vivo Effect of Blastogenesis and Suppressor Cell Activity In Graves' Disease", by Nily Goldrath, et al., Clin. Exp. Immunol. vol. 50: 62-69 (1982).
"Methimazole and Generation of Oxygen Radicals By Monocytes: Potential Role In Immunosuppression," by A. P. Weetman et al., British Medical Journal, vol. 28, Feb. 18, 1984, pp. 518-519.
"Inhibition of The Receptor For Interleukin-2 Induced By Carbimazole: Relevance For The Therapy of Autoimmune Thyroid Disease," by A. Signore, et al., Clin. Exp. Immunol. (1985) 60, pp. 111-116.
"The Effect of Antithyroid Drugs On B and T Cell Activity In Vitro," by R. Wilson, et al., Clinical Endocrinology (1988) 28, pp. 389-397.
"Inhibition of Immunoglobulin-Secreting Cells By Antithyroid Drugs," by Weiss and Davies, Journal of Clinical Endocrinology and Metabolism, vol. 53, No. 6, pp. 1223-1228, 1981.
"Peripheral Blood and Intrathyroidal Mononuclear Cell Populations in Patients With Autoimmune Thyroid Disorders Enumerated Using Monoclonal Antibodies," by J. R. Wall, et al., Journal of Clinical Endocrinology and Metabolism, vol. 56, pp. 164-169, 1982.
Hook Gregory
Waddell Frederick E.
LandOfFree
Uses for thioureylenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses for thioureylenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for thioureylenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2412419